469 related articles for article (PubMed ID: 17945478)
21. Establishment of novel mAb to human ERC/mesothelin useful for study and diagnosis of ERC/mesothelin-expressing cancers.
Ishikawa K; Segawa T; Hagiwara Y; Maeda M; Abe M; Hino O
Pathol Int; 2009 Mar; 59(3):161-6. PubMed ID: 19261093
[TBL] [Abstract][Full Text] [Related]
22. Mesothelin expression in human lung cancer.
Ho M; Bera TK; Willingham MC; Onda M; Hassan R; FitzGerald D; Pastan I
Clin Cancer Res; 2007 Mar; 13(5):1571-5. PubMed ID: 17332303
[TBL] [Abstract][Full Text] [Related]
23. Novel immunocytokine IL12-SS1 (Fv) inhibits mesothelioma tumor growth in nude mice.
Kim H; Gao W; Ho M
PLoS One; 2013; 8(11):e81919. PubMed ID: 24260587
[TBL] [Abstract][Full Text] [Related]
24. Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug Conjugates.
Chu Q
Curr Oncol Rep; 2023 Apr; 25(4):309-323. PubMed ID: 36763234
[TBL] [Abstract][Full Text] [Related]
25. Clinical impacts of mesothelin expression in gastrointestinal carcinomas.
Einama T; Kawamata F; Kamachi H; Nishihara H; Homma S; Matsuzawa F; Mizukami T; Konishi Y; Tahara M; Kamiyama T; Hino O; Taketomi A; Todo S
World J Gastrointest Pathophysiol; 2016 May; 7(2):218-22. PubMed ID: 27190694
[TBL] [Abstract][Full Text] [Related]
26. Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
Inami K; Kajino K; Abe M; Hagiwara Y; Maeda M; Suyama M; Watanabe S; Hino O
Oncol Rep; 2008 Dec; 20(6):1375-80. PubMed ID: 19020717
[TBL] [Abstract][Full Text] [Related]
27. MUC16 expression and risk of adenocarcinoma metastases to peritoneum, pleura, leptomeninges, and brain.
Johnson MD; Vito F; Xu H
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):250-3. PubMed ID: 20090516
[TBL] [Abstract][Full Text] [Related]
28. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity.
Chowdhury PS; Viner JL; Beers R; Pastan I
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):669-74. PubMed ID: 9435250
[TBL] [Abstract][Full Text] [Related]
29. Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P.
Zhang J; Qiu S; Zhang Y; Merino M; Fetsch P; Avital I; Filie A; Pastan I; Hassan R
Anticancer Res; 2012 Dec; 32(12):5151-8. PubMed ID: 23225411
[TBL] [Abstract][Full Text] [Related]
30. Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin.
Hassan R; Alewine C; Mian I; Spreafico A; Siu LL; Gomez-Roca C; Delord JP; Italiano A; Lassen U; Soria JC; Bahleda R; Thomas A; Steinberg SM; Peer CJ; Figg WD; Niederfellner G; Méresse Naegelen V; Pastan I
Cancer; 2020 Nov; 126(22):4936-4947. PubMed ID: 32870522
[TBL] [Abstract][Full Text] [Related]
31. Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors.
Hatterer E; Chauchet X; Richard F; Barba L; Moine V; Chatel L; Broyer L; Pontini G; Bautzova T; Juan F; Calloud S; Bosson N; Charreton M; Masternak K; Buatois V; Shang L
MAbs; 2020; 12(1):1739408. PubMed ID: 32191151
[TBL] [Abstract][Full Text] [Related]
32. Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect.
Golfier S; Kopitz C; Kahnert A; Heisler I; Schatz CA; Stelte-Ludwig B; Mayer-Bartschmid A; Unterschemmann K; Bruder S; Linden L; Harrenga A; Hauff P; Scholle FD; Müller-Tiemann B; Kreft B; Ziegelbauer K
Mol Cancer Ther; 2014 Jun; 13(6):1537-48. PubMed ID: 24714131
[TBL] [Abstract][Full Text] [Related]
33. New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma.
Zhang YF; Phung Y; Gao W; Kawa S; Hassan R; Pastan I; Ho M
Sci Rep; 2015 May; 5():9928. PubMed ID: 25996440
[TBL] [Abstract][Full Text] [Related]
34. Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.
Ho M; Hassan R; Zhang J; Wang QC; Onda M; Bera T; Pastan I
Clin Cancer Res; 2005 May; 11(10):3814-20. PubMed ID: 15897581
[TBL] [Abstract][Full Text] [Related]
35. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.
Rump A; Morikawa Y; Tanaka M; Minami S; Umesaki N; Takeuchi M; Miyajima A
J Biol Chem; 2004 Mar; 279(10):9190-8. PubMed ID: 14676194
[TBL] [Abstract][Full Text] [Related]
36. Molecular targets and targeted therapies for malignant mesothelioma.
Palumbo C; Bei R; Procopio A; Modesti A
Curr Med Chem; 2008; 15(9):855-67. PubMed ID: 18473795
[TBL] [Abstract][Full Text] [Related]
37. Control of human mesothelin-expressing tumors by DNA vaccines.
Chang CL; Wu TC; Hung CF
Gene Ther; 2007 Aug; 14(16):1189-98. PubMed ID: 17581599
[TBL] [Abstract][Full Text] [Related]
38. New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.
Onda M; Willingham M; Nagata S; Bera TK; Beers R; Ho M; Hassan R; Kreitman RJ; Pastan I
Clin Cancer Res; 2005 Aug; 11(16):5840-6. PubMed ID: 16115924
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer.
Tsujikawa T; Crocenzi T; Durham JN; Sugar EA; Wu AA; Onners B; Nauroth JM; Anders RA; Fertig EJ; Laheru DA; Reiss K; Vonderheide RH; Ko AH; Tempero MA; Fisher GA; Considine M; Danilova L; Brockstedt DG; Coussens LM; Jaffee EM; Le DT
Clin Cancer Res; 2020 Jul; 26(14):3578-3588. PubMed ID: 32273276
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers.
Hassan R; Bullock S; Premkumar A; Kreitman RJ; Kindler H; Willingham MC; Pastan I
Clin Cancer Res; 2007 Sep; 13(17):5144-9. PubMed ID: 17785569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]